UnitedHealth Group Incorporated (UNH · NYSE)

UNH · MARKET VIEW

Market view · as of Jul 27, 2026

Revenue (TTM)
$450.13B
+0.4% YoY
Gross margin
19.5%
EPS (latest q)
$6.38
vs $4.94 est · beat
52-wk position
92.4%
-3.6% vs 52w high · +1.3% 1mo

Price (last ~year)

UnitedHealth Group (UNH) reported second-quarter 2026 revenue of $112.03 billion and net income of $5.48 billion, with earnings of $6.38 per share exceeding analyst estimates. While year-over-year revenue growth remains flat at 0.4%, annual earnings rose 61.5% as gains in the Medicare and Optum segments helped offset higher medical costs. The stock is currently priced at $420.74, trading 23.8% above its 200-day moving average with a 15.4% gain over the last three months.

Valuation

Market cap
$382.09B
P/E
31.63
PEG
1.347
P/B
3.904
P/S
0.849
EV/EBITDA
18.77
Beta
0.633
Analyst target
$475.23

Quality & returns

Gross margin
19.5%
Operating margin
7.1%
Profit margin
3.1%
ROE
14.1%
ROA
4.4%

Price movement

Last
$420.74
1-month
+1.3%
3-month
+15.4%
RSI (14)
52
vs SMA200
+23.8%
52-wk position
92.4% -3.6% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$112.03B$7.99B$5.48B$8.97B
2026-03-31$111.72B$8.99B$6.28B$10.09B
2025-12-31$113.22B$380.0M$10.0M$1.37B
2025-09-30$113.16B$4.32B$2.35B$5.33B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots